| 注册
首页|期刊导航|心脑血管病防治|阿托伐他汀钙预治疗在急性冠状动脉综合征患者PCI术中的应用价值

阿托伐他汀钙预治疗在急性冠状动脉综合征患者PCI术中的应用价值

陈德奎 葛水秀

心脑血管病防治2017,Vol.17Issue(4):269-272,4.
心脑血管病防治2017,Vol.17Issue(4):269-272,4.DOI:10.3969/j.issn.1009-816x.2017.04.08

阿托伐他汀钙预治疗在急性冠状动脉综合征患者PCI术中的应用价值

Value of Atorvastatin Calcium Pre-treatment in Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention

陈德奎 1葛水秀1

作者信息

  • 1. 242000 安徽省宣城市中心医院
  • 折叠

摘要

Abstract

Objective To explore the value of atorvastatin calcium pre-treatment in patients with acute coronary syndrome (ACS) undergoing percutaneous coronary intervention (PCI).Methods 80 patients with acute coronary syndrome were randomly and equally allocated into treated group (n =40) and control group (n =40).The treated group was given atorvastatin calcium for 3 month before PCI while the other group was treated by PCI for the first time and without statins pre-treatment.The inflanmatory reaction and changes of myocardial injury markers were monitored at different time points (before PCI and 12 h and 24 h after PCI).TIMI flow grading of target vessel antegrade flow at 20 min after PCI was observed.The incidence of major adverse cardiovascular events (MACE) was followed up after PCI for 1 month.Results Compared with the control group,the levels of serum total cholesterol and triglyceride were significantly lower in treated group than those in control group (all P < 0.05).The levels of cTnT,CK-MB,IL-6 and hs-CRP were lower in treated group than those in control group before PCI and at 12 h and 24 h after PCI (all P < 0.05).TIMI flow grading and TMPG flow grading were better in treated group than those in control group (all P < 0.05).The incidence of nonreflow during PCI was lower in treated group than that in control group (P < 0.05).The incidence of MACE was significantly lower in treated group than that in control group (P < 0.05) 1 month after PCI.Conclusions Atorvastatin calcium pre-treatment can not only alleviate myocardial injury and inflammatory reaction,but also improve postoperative blood perfusion to a certain extent and reduce short-term incidence of MACE in ACS patients.

关键词

阿托伐他汀钙/急性冠状动脉综合征/经皮冠状动脉介入治疗/预后

Key words

Atorvastatin calcium/Acute coronary syndrome/Percutaneous coronary intervention/Prognosis

分类

医药卫生

引用本文复制引用

陈德奎,葛水秀..阿托伐他汀钙预治疗在急性冠状动脉综合征患者PCI术中的应用价值[J].心脑血管病防治,2017,17(4):269-272,4.

心脑血管病防治

OACSTPCD

1009-816X

访问量0
|
下载量0
段落导航相关论文